This is a serious alert for anyone managing diabetes. The Food and Drug Administration (FDA) has issued a critical warning about malfunctioning blood glucose monitoring devices from Abbott. These faulty devices have been tragically linked to seven deaths and over 700 severe injuries globally.
The specific devices in question are Abbott’s FreeStyle Libre glucose monitors. These devices, which use a sensor applied to the arm, have been providing users with incorrect glucose readings. The FDA flagged this issue on December 2nd, urging immediate attention.
The Dangers of Incorrect Readings
Why is this so critical? If undetected, consistently low glucose readings can lead people with diabetes to make dangerous treatment decisions. This could mean consuming too many carbohydrates or delaying or skipping insulin doses. The FDA warns that these incorrect decisions can lead to serious health risks, including potential injury or even death.
The FDA is classifying this as a ‘potentially high-risk issue’ and will continue to provide updates as more information becomes available. It’s a stark reminder of how vital accurate medical device readings are for managing chronic conditions.
Which Devices Are Affected?
Abbott has identified that approximately 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors are affected by this malfunction. Importantly, the Libre 3 readers and mobile apps themselves are not impacted. Other FreeStyle Libre models, such as the 14-day, 2, 2 Plus, or Libre Pro, are also not part of this issue, nor are other Abbott biowearables.
The company has stated that they have identified and resolved the root cause of the problem, which stemmed from a single production line. Abbott assures that they are continuing production and do not anticipate significant supply disruptions for the affected sensors.
What You Should Do
Abbott is advising customers to check if their sensors are affected. If they are, the company recommends stopping use of the device immediately and disposing of it. While the U.S. has reported around 60 injuries among the global total, none of these were fatal.
To determine if your sensor is part of the recall, you can visit FreeStyleCheck.com. Abbott is providing replacements at no cost to affected users. This proactive step is crucial for ensuring patient safety.
Diabetes in the U.S.
This situation underscores the importance of reliable health technology, especially for the millions living with diabetes. According to the Centers for Disease Control and Prevention (CDC), about 38 million people in the U.S. are living with diabetes, and it remains the seventh leading cause of death in the country. Ensuring the accuracy and safety of monitoring devices is paramount.
If you use an Abbott FreeStyle Libre glucose monitor, have you checked if your device is affected? Share your experience and any concerns in the comments below!